Facebook
Twitter
LinkedIn
ForwardData-informed Approaches for the Management of Angiosarcoma in the Modern Era
Angiosarcoma is rare, and often portends adverse outcomes. Those who receives multi-modal care generally experience the best cancer outcomes. However, guidelines to inform approach are limited. Further education is needed to advocate for high-quality care in this uncommon setting. This webinar provides learners with guidance on how to best approach such difficult cases and advocate for when radiation could help patients afflicted with this deadly disease.
Target Audience
This activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, nurses, physicists, dosimetrists, diagnostic radiologists, pathologists, radiation therapists, allied healthcare professionals and residents.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Understand the biology and patterns of relapse for angiosarcoma.
- Detail clinical research informing patterns of practice.
- Review opportunities for multi-modal care in appropriately selected patients with angiosarcoma.
- Parul Barry, MD, is employed by UPMC Radiation Oncology. Dr. Barry receives travel expenses and grant research funding from ASTRO and ACRO. Dr. Barry receives grant/research funding from the Beckwith Foundation, Silverlon and Philanthropy. Dr. Barry receives honoraria from Elsevier Pathways and the Pittsburgh Foundation. Dr. Barry serves in an uncompensated role with ARS and ABS Guidelines. Dr. Barry is Chair of Education on the HEDI Council of ASTRO; Director of Research and Scientific Program with the Women in Medicine Summit; Senior Associate Editor for the Journal on Rare Tumors; and is a Senior Advisory Committee Member for the Society of Women in Radiation Oncology (SWRO).
- Meng Welliver, MD, PhD, is employed by Mayo Clinic Alix School of Medicine.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
Available Credit
1.00 Certificate of Attendance
This activity was designated for 1.00 AMA PRA Category 1 Credit.™
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.